Date :
Place : United States, San Jose
Website :https://bit.ly/3gCafZr
Contact Person:Ashutos Swain
Description:
Data Integrity has become a non-compliance area often observed by the FDA and reported within Form FDA 483s and Warning Letters. While various governments have observed this on a world-wide basis, the FDA has been reporting its occurrence off-shore with a greater frequency than usually observed within the United States. A lack of Data Integrity hints of a Company being outside of compliance and questions the quality of the product being produced.Deadline for abstracts/proposals : 18th October 2021
Organized By :Complianceonline
Keynote Speakers :
Check the event website for more details.